DK1455839T3 - Heterobifunktioneller poly(ethylenglycol)-derivater og fremgangsmåder til fremstilling heraf - Google Patents
Heterobifunktioneller poly(ethylenglycol)-derivater og fremgangsmåder til fremstilling herafInfo
- Publication number
- DK1455839T3 DK1455839T3 DK99951885.5T DK99951885T DK1455839T3 DK 1455839 T3 DK1455839 T3 DK 1455839T3 DK 99951885 T DK99951885 T DK 99951885T DK 1455839 T3 DK1455839 T3 DK 1455839T3
- Authority
- DK
- Denmark
- Prior art keywords
- heterobifunctional
- poly
- derivatives
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polyethers (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1999/023536 WO2001026692A1 (en) | 1999-10-08 | 1999-10-08 | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1455839T3 true DK1455839T3 (da) | 2013-05-06 |
Family
ID=22273776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99951885.5T DK1455839T3 (da) | 1999-10-08 | 1999-10-08 | Heterobifunktioneller poly(ethylenglycol)-derivater og fremgangsmåder til fremstilling heraf |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1455839B1 (da) |
| JP (1) | JP4344110B2 (da) |
| KR (1) | KR100499655B1 (da) |
| CN (1) | CN1284603C (da) |
| AU (1) | AU781336B2 (da) |
| BR (1) | BR9917517A (da) |
| CA (1) | CA2386762C (da) |
| CY (1) | CY1114128T1 (da) |
| DK (1) | DK1455839T3 (da) |
| ES (1) | ES2404685T3 (da) |
| HU (1) | HU228491B1 (da) |
| IL (2) | IL148890A0 (da) |
| MX (1) | MXPA02003540A (da) |
| NO (1) | NO331781B1 (da) |
| NZ (1) | NZ518143A (da) |
| PT (1) | PT1455839E (da) |
| WO (1) | WO2001026692A1 (da) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100361933B1 (ko) | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
| WO2001093914A2 (en) | 2000-06-08 | 2001-12-13 | La Jolla Pharmaceutical Company | Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| US6761824B2 (en) | 2000-08-17 | 2004-07-13 | Reeve Lorraine E | Process for the fractionation of polymers |
| US7118737B2 (en) | 2000-09-08 | 2006-10-10 | Amylin Pharmaceuticals, Inc. | Polymer-modified synthetic proteins |
| US7829074B2 (en) | 2001-10-18 | 2010-11-09 | Nektar Therapeutics | Hydroxypatite-targeting poly(ethylene glycol) and related polymers |
| TW593427B (en) | 2000-12-18 | 2004-06-21 | Nektar Therapeutics Al Corp | Synthesis of high molecular weight non-peptidic polymer derivatives |
| US7053150B2 (en) | 2000-12-18 | 2006-05-30 | Nektar Therapeutics Al, Corporation | Segmented polymers and their conjugates |
| US7550512B2 (en) | 2001-11-28 | 2009-06-23 | Keio University | Medical polymers and uses thereof |
| JP3493608B2 (ja) * | 2001-11-28 | 2004-02-03 | 学校法人慶應義塾 | 医用高分子及びその用途 |
| GB0209539D0 (en) * | 2002-04-26 | 2002-06-05 | Avecia Ltd | Monomer Polymer and process |
| MXPA05000796A (es) | 2002-07-24 | 2005-04-19 | Hoffmann La Roche | Aditivos de acidos polialquilenglicolicos. |
| US20040062748A1 (en) | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| US8129330B2 (en) | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| WO2004035657A1 (en) * | 2002-10-15 | 2004-04-29 | Baxter International Inc. | Process for the preparation of polyethylene glycol bis amine |
| EP1616003A4 (en) | 2002-12-30 | 2007-06-20 | Gryphon Therapeutics Inc | WATER-SOLUBLE THIOESTER AND SELENOESTER COMPOUNDS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| DE60322111D1 (de) | 2002-12-31 | 2008-08-21 | Nektar Therapeutics Al Co | Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen |
| DK2599502T3 (da) | 2003-04-11 | 2017-04-18 | Antriabio Inc | Fremgangsmåde til fremstilling af stedspecifikke proteinkonjugater |
| EP1725572B1 (de) | 2003-11-05 | 2017-05-31 | AGCT GmbH | Makromolekulare nukleotidverbindungen und methoden zu deren anwendung |
| US20050214250A1 (en) * | 2003-11-06 | 2005-09-29 | Harris J M | Method of preparing carboxylic acid functionalized polymers |
| EP1868652A2 (en) | 2005-04-05 | 2007-12-26 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Method for shielding functional sites or epitopes on proteins |
| CA2619709C (en) * | 2005-08-26 | 2012-05-01 | Novo Nordisk A/S | A method of modifying a macromolecular system |
| ATE425204T1 (de) * | 2005-08-26 | 2009-03-15 | Novo Nordisk As | Verfahren zur modifizierung eines makromolekularen systems |
| BRPI0621841B8 (pt) | 2006-07-06 | 2021-05-25 | Daewoong Co Ltd | formulação líquida |
| US7985783B2 (en) | 2006-09-21 | 2011-07-26 | The Regents Of The University Of California | Aldehyde tags, uses thereof in site-specific protein modification |
| CN102612362A (zh) | 2009-08-05 | 2012-07-25 | 皮里斯股份公司 | 脂质运载蛋白突变蛋白的控制释放制剂 |
| EP2494073B1 (de) | 2009-10-26 | 2017-11-29 | AGCT GmbH | Konjugate von nukleotiden und methoden zu deren anwendung |
| CN103747807B (zh) | 2011-07-05 | 2016-12-07 | 比奥阿赛斯技术有限公司 | P97‑抗体缀合物和使用方法 |
| CA3140358A1 (en) | 2012-07-31 | 2014-02-06 | Bioasis Technologies, Inc. | Dephosphorylated lysosomal storage disease proteins and methods of use thereof |
| AU2013341711A1 (en) | 2012-11-12 | 2015-05-21 | Redwood Bioscience, Inc. | Compounds and methods for producing a conjugate |
| US9310374B2 (en) | 2012-11-16 | 2016-04-12 | Redwood Bioscience, Inc. | Hydrazinyl-indole compounds and methods for producing a conjugate |
| WO2014078733A1 (en) | 2012-11-16 | 2014-05-22 | The Regents Of The University Of California | Pictet-spengler ligation for protein chemical modification |
| CN103044677A (zh) * | 2012-12-28 | 2013-04-17 | 上海景宇生物科技有限公司 | 一种异端基遥爪聚乙二醇及其制备方法 |
| AU2014243816B2 (en) | 2013-03-13 | 2019-01-31 | Bioasis Technologies Inc. | Fragments of p97 and uses thereof |
| US20150093399A1 (en) | 2013-08-28 | 2015-04-02 | Bioasis Technologies, Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| CN115504924A (zh) | 2013-11-27 | 2022-12-23 | 雷德伍德生物科技股份有限公司 | 肼基-吡咯并化合物及用于生成缀合物的方法 |
| CN104774161B (zh) * | 2014-01-13 | 2017-08-25 | 成都福瑞康生物科技有限公司 | 多肽、蛋白质peg修饰剂合成方法 |
| PL3359515T3 (pl) * | 2015-10-07 | 2020-07-27 | Elementis Specialties, Inc. | Środek zwilżający i przeciwpieniący |
| EP3373937B1 (en) | 2015-11-09 | 2021-12-22 | R.P. Scherer Technologies, LLC | Anti-cd22 antibody-maytansine conjugates and methods of use thereof |
| KR102247701B1 (ko) * | 2016-02-26 | 2021-05-03 | 한미정밀화학주식회사 | 폴리에틸렌글리콜 디알데히드 유도체의 제조방법 |
| AU2017250778B2 (en) | 2016-04-15 | 2021-09-23 | Beckman Coulter, Inc. | Photoactive macromolecules and uses thereof |
| JP7097885B2 (ja) | 2016-12-12 | 2022-07-08 | ベクトン・ディキンソン・アンド・カンパニー | 水溶性ポリマー色素 |
| CN119286279A (zh) | 2017-12-26 | 2025-01-10 | 贝克顿·迪金森公司 | 深紫外线可激发的水溶剂化聚合物染料 |
| EP3775052B1 (en) | 2018-03-30 | 2024-06-05 | Becton, Dickinson and Company | Water-soluble polymeric dyes having pendant chromophores |
| EP3813867A1 (en) | 2018-07-22 | 2021-05-05 | Bioasis Technologies Inc. | Treatment of lymmphatic metastases |
| EP3950655B1 (en) * | 2019-03-29 | 2023-11-15 | NOF Corporation | Method for producing hetero type monodisperse polyethylene glycol derivative |
| US20210355468A1 (en) | 2020-05-18 | 2021-11-18 | Bioasis Technologies, Inc. | Compositions and methods for treating lewy body dementia |
| US20210393787A1 (en) | 2020-06-17 | 2021-12-23 | Bioasis Technologies, Inc. | Compositions and methods for treating frontotemporal dementia |
| CN113583230A (zh) * | 2021-06-30 | 2021-11-02 | 苏州欣影生物医药技术有限公司 | 一种peg双胺选择性反应制备异双官能团的方法 |
| EP4155349A1 (en) | 2021-09-24 | 2023-03-29 | Becton, Dickinson and Company | Water-soluble yellow green absorbing dyes |
| US20250383357A1 (en) | 2022-07-01 | 2025-12-18 | Beckman Coulter, Inc. | Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives |
| WO2024044327A1 (en) | 2022-08-26 | 2024-02-29 | Beckman Coulter, Inc. | Dhnt monomers and polymer dyes with modified photophysical properties |
| CN115959992A (zh) * | 2022-12-13 | 2023-04-14 | 武汉翱飞科技有限公司 | 一种单分子量聚乙二醇单乙酸的合成方法 |
| EP4680677A1 (en) | 2023-03-17 | 2026-01-21 | Beckman Coulter, Inc. | Benzothienopyrrole cyanine dyes |
| CN121866309A (zh) | 2023-09-21 | 2026-04-14 | 贝克曼库尔特有限公司 | 用于流式细胞术的二氢菲（dhp）桥接染料 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0867190B1 (en) * | 1995-05-10 | 2007-12-26 | Kyowa Hakko Kogyo Co., Ltd. | Cytotoxin complexes comprising dipeptides |
| US5672662A (en) * | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| US20020064546A1 (en) * | 1996-09-13 | 2002-05-30 | J. Milton Harris | Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| PT1053019E (pt) * | 1998-01-07 | 2004-04-30 | Debio Rech Pharma Sa | Acrilatos de poli(etileno-glicol) heterobifuncional degradaveis e geles e conjugados derivados dos mesmos |
| JP4078032B2 (ja) * | 1998-03-12 | 2008-04-23 | ネクター セラピューティックス エイエル，コーポレイション | 近位の反応性基を持つポリ（エチレングリコール）誘導体 |
-
1999
- 1999-10-08 DK DK99951885.5T patent/DK1455839T3/da active
- 1999-10-08 JP JP2001529753A patent/JP4344110B2/ja not_active Expired - Lifetime
- 1999-10-08 EP EP99951885A patent/EP1455839B1/en not_active Expired - Lifetime
- 1999-10-08 KR KR10-2002-7004507A patent/KR100499655B1/ko not_active Expired - Lifetime
- 1999-10-08 PT PT99951885T patent/PT1455839E/pt unknown
- 1999-10-08 IL IL14889099A patent/IL148890A0/xx active IP Right Grant
- 1999-10-08 CA CA002386762A patent/CA2386762C/en not_active Expired - Lifetime
- 1999-10-08 CN CNB998169714A patent/CN1284603C/zh not_active Expired - Lifetime
- 1999-10-08 NZ NZ518143A patent/NZ518143A/en not_active IP Right Cessation
- 1999-10-08 HU HU0203149A patent/HU228491B1/hu unknown
- 1999-10-08 AU AU64230/99A patent/AU781336B2/en not_active Expired
- 1999-10-08 WO PCT/US1999/023536 patent/WO2001026692A1/en not_active Ceased
- 1999-10-08 ES ES99951885T patent/ES2404685T3/es not_active Expired - Lifetime
- 1999-10-08 MX MXPA02003540A patent/MXPA02003540A/es active IP Right Grant
- 1999-10-08 BR BR9917517-7A patent/BR9917517A/pt not_active Application Discontinuation
-
2002
- 2002-03-26 IL IL148890A patent/IL148890A/en not_active IP Right Cessation
- 2002-04-02 NO NO20021555A patent/NO331781B1/no not_active IP Right Cessation
-
2013
- 2013-04-23 CY CY20131100332T patent/CY1114128T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02003540A (es) | 2003-09-12 |
| KR20020040841A (ko) | 2002-05-30 |
| HU228491B1 (en) | 2013-03-28 |
| NZ518143A (en) | 2004-04-30 |
| EP1455839A1 (en) | 2004-09-15 |
| BR9917517A (pt) | 2002-07-30 |
| KR100499655B1 (ko) | 2005-07-07 |
| CA2386762A1 (en) | 2001-04-19 |
| IL148890A0 (en) | 2002-09-12 |
| AU6423099A (en) | 2001-04-23 |
| JP2003511422A (ja) | 2003-03-25 |
| NO331781B1 (no) | 2012-03-26 |
| ES2404685T3 (es) | 2013-05-28 |
| PT1455839E (pt) | 2013-04-24 |
| CY1114128T1 (el) | 2016-07-27 |
| CN1374875A (zh) | 2002-10-16 |
| CA2386762C (en) | 2009-06-16 |
| AU781336B2 (en) | 2005-05-19 |
| NO20021555D0 (no) | 2002-04-02 |
| NO20021555L (no) | 2002-06-04 |
| WO2001026692A1 (en) | 2001-04-19 |
| CN1284603C (zh) | 2006-11-15 |
| IL148890A (en) | 2007-09-20 |
| HUP0203149A2 (en) | 2002-12-28 |
| EP1455839B1 (en) | 2013-01-23 |
| JP4344110B2 (ja) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1455839T3 (da) | Heterobifunktioneller poly(ethylenglycol)-derivater og fremgangsmåder til fremstilling heraf | |
| NO2010019I1 (no) | 6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin | |
| NO20022086D0 (no) | Antidiabetisk formulering og fremgangsmåte | |
| NO20001409L (no) | Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger | |
| IS6197A (is) | Aðferð og búnaður til að koma lyfjablöndum á úðaform | |
| DE60028849D1 (de) | Sterilisationsmethode | |
| NO992339D0 (no) | Farmas°ytiske formuleringer | |
| NO995386D0 (no) | Polybuten-1-(ko)polymerer og fremgangsmÕte for fremstilling av slike | |
| PT1181397E (pt) | Electrocatalisador de rodio e metodo de preparacao | |
| ID29089A (id) | Sediaan farmasi moksifloksasin | |
| NO20002584D0 (no) | Brønnreferanseapparat og fremgangsmÕte | |
| DE60122160D1 (de) | Antennenstruktur und zugehöriges verfahren | |
| DE60033056D1 (de) | Wafer fördersystem | |
| NO20030759D0 (no) | 10-aryl-11-HBENZO(b)fluorenderivater og analoger for medisinsk anvendelse | |
| DE60013073D1 (de) | Aufblasventil | |
| DE50014156D1 (de) | Rastverbindung | |
| ID30032A (id) | Formulasi farmasi | |
| ATE250092T1 (de) | Polyolformulierung | |
| AR025867A1 (es) | Formulacion portasdora farmaceutica | |
| NO20010682D0 (no) | Fosforylerte polymerer og konjugater derav | |
| DK1088818T3 (da) | Quinolin-4-yl-derivater | |
| FI991496A0 (fi) | Menetelmä ja järjestely kaapeliyhteyksien tarkistamiseksi | |
| DE50010263D1 (de) | Arbeitsbühne | |
| NO20023160L (no) | Polymerisasjonskatalysatorer og fremgangsmåter derav | |
| DK1200446T3 (da) | Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder |